|
WO2020086730A1
|
|
Alk2 antibodies and methods of use thereof
|
|
AU2019266314A1
|
|
Activin receptor type iia variants and methods of use thereof
|
|
AU2019206634A1
|
|
Activin receptor type IIB variants and methods of use thereof
|
|
US2021030841A1
|
|
Activin receptor type iia variants and methods of use thereof
|
|
AU2018364668A1
|
|
Activin receptor type lla variants and methods of use thereof
|
|
AU2017357931A1
|
|
GDNF fusion polypeptides and methods of use thereof
|
|
CN110461349A
|
|
Activin receptor IIA type variant and its application method
|
